Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: audit pharma

  • Home
  • audit pharma
  • Page 50
Quality Assurance under GMP

Criteria for Batch Rejection in Pharmaceutical Industry

Criteria for Batch Rejection in Pharmaceutical Industry Understanding the Criteria for Rejecting Batches in the…
GMP Audits and Inspections

Audit frequency not justified through supplier criticality assessment

Audit frequency not justified through supplier criticality assessment Justifying Audit Frequency Through Supplier Criticality Assessments…
Quality Assurance under GMP

Handling of Product Release Following Audit Observations

Handling of Product Release Following Audit Observations Strategies for Managing Product Release Post-Audit Findings The…
GMP Audits and Inspections

Failure to reassess supplier risk after significant changes

Failure to reassess supplier risk after significant changes Understanding the Failure to Reassess Supplier Risk…
Quality Assurance under GMP

Linkage Between Release Decisions and Quality Review Systems

Linkage Between Release Decisions and Quality Review Systems Understanding the Connection Between Release Decisions and…
GMP Audits and Inspections

Insufficient auditor competency in supplier qualification reviews

Insufficient auditor competency in supplier qualification reviews Challenges with Auditor Competence in Supplier Qualification Processes…
Quality Assurance under GMP

Common Errors in Product Disposition Processes

Common Errors in Product Disposition Processes Identifying Common Mistakes in Product Disposition Processes In the…
GMP Audits and Inspections

Regulatory risks from weak technical agreements and audit controls

Regulatory risks from weak technical agreements and audit controls Mitigating Regulatory Risks from Insufficient Technical…
Quality Assurance under GMP

Regulatory Impact of Releasing Product with OOS Results

Regulatory Impact of Releasing Product with OOS Results Regulatory Considerations for Product Release with Out-of-Specification…
Quality Assurance under GMP

Regulatory Impact of Releasing Product with OOS Results

Regulatory Impact of Releasing Product with OOS Results Regulatory Implications of Product Release Amid Out-of-Specification…

Posts pagination

Previous 1 … 49 50 51 … 82 Next

Recent Posts

  • Weak Integration of Laboratory Practices with Quality Systems
  • Regulatory Risks from Weak QA Governance Systems
  • Documentation Gaps in GLP and GMP Records
  • Audit Observations Related to QA Oversight Failures
  • Failure to Align Lab Practices with Regulatory Expectations

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Uncategorized
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.